Predictive value of copeptin as a severity marker of community-acquired pneumonia
| Autor: | Gamal B Mohamed, Kalid Salah, Madeha Abdellah Saed, Abdelrahman Mamdouh Saed, Abdelhakeem Abdelmohsen Abdelhakeem |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
lcsh:R5-920 Respiratory distress business.industry Copeptin 030209 endocrinology & metabolism medicine.disease Predictive value Community acquired pneumonia 03 medical and health sciences Pneumonia 0302 clinical medicine Community-acquired pneumonia 030220 oncology & carcinogenesis Internal medicine Significant positive correlation Healthy control Medicine Original Article business lcsh:Medicine (General) Cause of death Outcome |
| Zdroj: | Electronic Physician Electronic Physician, Vol 9, Iss 7, Pp 4880-4885 (2017) |
| ISSN: | 2008-5842 |
| Popis: | Background: Pneumonia is the leading cause of death in children. Few studies have explored the predictive value of copeptin in pediatric pneumonia. Aim: This study aimed to assess the role of copeptin as a marker of severity of community-acquired pneumonia (CAP). Methods: This prospective case-control study was carried out at Minia University Children’s Hospital in Minia (Egypt) from January to December 2016. Eighty children aged from 2 months to 42 months were enrolled in this study and were classified into group 1 (40 children with clinical, laboratory and radiological evidence of pneumonia) and group 2 (40 apparently healthy control). Serum copeptin level was assayed for all enrolled children. Results: Mean serum copeptin level was significantly higher in pneumonic patients (985.7±619) pg/ml compared to controls (519±308.2) pg/ml (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|